Kamna Singh Balhara, M.A., M.D.

• Assistant Professor of Emergency Medicine

https://www.hopkinsmedicine.org/profiles/results/directory/profile/10004264/kamna-balhara

Secretagogues promote intestinal secretion erectile dysfunction medication samples order sildenafila pills in toronto, which produces softer stools and accelerates intestinal transit safe erectile dysfunction pills generic sildenafila 100 mg without a prescription. Refractory Cases: the Role of Surgery and Neuromodulation Patients with slow-transit constipation of neuropathic origin are often refractory to aggressive medical treatments impotence test sildenafila 50 mg buy with mastercard, and therefore surgery should be considered impotence pump buy generic sildenafila from india. Colectomy and ileostomy or ileorectal anastomosis are usually required erectile dysfunction pills at gnc purchase sildenafila 100 mg line, though segmental colonic resection may be considered in certain situations, especially in children. Surgery should only be considered as the last resort, and it will not be useful unless dyssynergia has been corrected. Furthermore, following colectomy, patients may develop diarrhea and/or fecal incontinence and small-bowel adhesions. The first sacral anterior root stimulator was implanted in 1976, to improve neurogenic bladder after spinal injury. Efforts should be made to make a positive diagnosis with colorectal physiological tests. Biofeedback Therapy for Dyssynergic Defecation Management of dyssynergic defecation includes the standard treatment for constipation, including diet, laxatives, and pelvicfloor exercise, as well as specific treatments for neuromuscular conditioning and sensory training. Biofeedback therapy attempts to restore the normal defecation pattern through an instrumentbased education program that reinforces regular behavior via repeated training. This involves diaphragmatic breathing exercises to improve the abdominal push effort and manometric-guided pelvic-floor relaxation followed by simulated defecation training. Sensory training is also performed, to improve the thresholds of stooling awareness. Intermittent inflation and deflation of the rectal balloon is used to educate patients on newer thresholds of rectal perception. Upon completion of training, periodic reinforcement can provide good long-term outcome. Biofeedback therapy also provides a more sustained improvement of bowel symptoms and anorectal function in the long term [28]. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. Altered periodic rectal motor activity: a mechanism for slow transit constipation. Severe chronic constipation of young women: "idiopathic slow transit constipation. Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. Evaluation of gastrointestinal transit in clin- 19 20 21 22 23 24 25 26 27 28 29 ical practice: position paper of the American and European Neurogastroenterology and Motility Societies. High resolution and high definition anorectal manometry and pressure topography: diagnostic advance or a new kid on the block Translumbar and transsacral motorevoked potentials: a novel test for spino-anorectal neuropathy in spinal cord injury. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. It accounts for significant health care impact and has a high comorbidity with psychiatric disorders. The pain experience relates primarily to the impaired central processing of afferent signals, leading to disinhibition and severe symptoms. In the absence of alarm symptoms, an extensive workup is not required, as a cost-effective approach can be used to rule out an alternative or co-existing diagnosis. As there is no cure, effective treatment hinges on a biopsychosocial approach, with emphasis on a trusting doctor­patient relationship and negotiating reasonable treatment goals. Therapeutic options include centrally acting pharmacological agents and psychological therapies that focus more on adaptive coping than on complete cure. Antidepressants are the mainstay of pharmacotherapy, which also aims to target associated psychiatric comorbidities. It is commonly associated with other painful conditions, such as fibromyalgia, and it seems to fulfill criteria for diagnosis of a somatoform pain disorder under psychiatric nosology. In one Israeli study, respondents were almost entirely women [4], but a Canadian study found no gender difference [5]. Case A 45-year-old female is referred to a gastroenterologist by her primary care physician for refractory abdominal pain. She describes the pain as "wrenching" and "squeezing," 9­10/10 in severity, generalized, and present nearly all the time. There does not appear to be any relation between her pain and belching, eating, defecation, or passing flatus. She has not experienced any weight loss, fever, chills, constipation, diarrhea, melena, hematochezia, nausea, or vomiting. Surgical history includes cholecystectomy, appendectomy, hysterectomy, and an explorative laparoscopy for evaluation of dysmenorrhea. This supports that Practical Gastroenterology and Hepatology Board Review Toolkit, Second Edition. Criteria are fulfilled for the last 3 months, with symptom onset at least 6 months prior to diagnosis. Case Continued When examining the patient, she is diffusely tender, but negative for hepatosplenomegaly, ascites, rebound, or masses. Diagnosis Evaluation proceeds using a clinical and psychosocial approach, with emphasis on the physical exam and observed behaviors [1, 2]. Physical examination must be thorough, and by definition will not be associated with significant abnormalities, though overlap with other medical conditions can occur. The presence of abdominal scars might prompt interrogation of symptoms preceding surgery, exposing exploratory versus therapeutic investigations. Abdominal wall pain should be excluded using the Carnett test, in which it increases with head raising and contraction of the rectus abdominis muscle, while visceral pain decreases. This abdominal pain may occur in the setting of other painful symptoms, suggesting a concurrent somatization disorder or perhaps overlap with other functional pain conditions such as fibromyalgia [1]. Features suggestive of a structural disorder include acute onset of symptoms, variable or intermittent intensity of pain, focal location of discomfort, positive diagnostic tests, response to promotility and/or anti-inflammatory agents, and improvement of symptoms with nasogastric suction or fasting. The physician explains that total pain relief is unlikely; however, the ultimate goal will be to reach a point where her pain no longer disrupts her daily activities. She accepts the diagnosis but wants something to stop her pain right now: a medication like hydromorphone, which has worked well in the past. The physician explains that unfortunately, medications like Dilaudid are not effective for her type of pain and may cause other problems, such as narcotic bowel syndrome, which will confound her symptoms. She seems initially anxious at starting this type of medication, but is more amenable after understanding the rationale behind it. The physician asks her to return for a short session in 2 weeks to assess her progress, medication dosage, and any need for referral for psychotherapy. It is key to demonstrate empathy, to educate the patient, to validate their illness, and to reassure them, but it is equally as important to negotiate treatment, thereby establishing reasonable limits of time and effort (Table 67. The focus of treatment is on management of symptoms, as opposed to targeting a cure [1, 2]. The rationale is that these drugs can modulate pain perception by modulating central regulatory mechanisms, and to some degree hypervigilance and visceral hypersensitivity. Doses of antidepressants are generally lower than those prescribed for clinical depression [3, 15]. In narcotic bowel syndrome, persistent use of narcotics leads to progression in the frequency, duration, and intensity of pain episodes. Gabapentin and pregabalin are also prescribed for chronic neuropathic pain conditions. The benefit of these agents in treating visceral or central pain syndromes has not been established, but a few case reports have suggested a reduction in visceral pain [15]. Based on clinical experience, buspirone, a non-benzodiazepine azapirone with antianxiety properties, may enhance the analgesic effect of antidepressants. Tertiary amines (imipramine and amitriptyline) Starting dose 10­25 mg Escalating dose Increase by 25 mg increments weekly, up to max. They are intended to be used in conjunction with one of the preceding medications, in order to augment the effects of both. Combination treatments involving two classes of antidepressants, addition of gabapentin or another neuropathic pain agent, or Chronic Functional Abdominal Pain 411 Table 67. Increased colonic pain sensitivity in irritable bowel syndrome is the result of increased tendency to report pain than increased neurosensory sensitivity. Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Cognitive behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Other modalities may be found at a multidisciplinary pain treatment center and should be sought for more refractory patients. Prognosis the quality of life in patients with functional abdominal pain is generally poor. Take Home Points r Functional abdominal pain is a debilitating chronic functional pain syndrome that is not explained by a structural or metabolic disorder. It includes pharmacotherapy, non-pharmacotherapy, and combination treatments aimed at improving symptom control. Despite their high prevalence, the pathophysiology of these symptoms is not always obvious. Due to the lack of defined and effective therapy for bloating, the symptoms are often ignored in the treatment of conditions where bloating is common. Though the treatment of bloating and distension is challenging, this set of symptoms should not be underappreciated, as an understanding of the pathophysiology and effective treatments for bloating and abdominal distension will have a great impact in patient care. This chapter addresses the epidemiology, pathophysiology, and treatment options for this constellation of symptoms. While functional bowel diseases are commonly associated with bloating and abdominal distension, it is important to recognize that many non-functional conditions can produce these symptoms as well (Table 68. These include conditions such as mechanical obstruction, systemic diseases, and medications. Though bloating is known to be a symptom of such conditions, there are limited epidemiologic data to support the prevalence of each. Patient Evaluation When evaluating a patient with bloating, it is vital to thoroughly review their history. Any medication that has a slowing effect on the intestinal tract or even that causes constipation has the potential to contribute to bloating. Diet is extremely important in patient evaluation, including a history of probiotic use. Vegetarianism (especially veganism) causes significant bloating, due to the high-residue diet. Legumes are classically associated with bloating, and the increasing use of other nondigestible products has increased the presentation of bloating in the primary care clinic. Sucralose and alcohol sugars are commonly used in diet products such as "sugar-free gum" and beverages. These non-absorbed carbohydrates are readily fermentable and contribute to symptoms. It is also important to rule out red-flag symptoms that can represent more sinister conditions, such as weight loss and hematochezia. When present, red-flag symptoms warrant further evaluation, including imaging or endocopy to rule out inflammatory or malignant disease. The age of the patient can also be a contributing factor, as the risk of malignancy increases with age. Given the long list of etiologic factors for bloating and distension, this chapter will focus on a few key areas. It is beyond the scope of this chapter to outline the workup or evaluation of all causes of bloating. However, it is important to consider the wide differential diagnosis when approaching these patients, as in Table 68. However, there are many confounding variables in the assessment of bloating that can affect these rates, including medications. Since many conditions or situations can lead to bloating and distension even in normal humans. It is therefore important when discussing the etiology of this complex to look at underlying causes and their epidemiology. In Practical Gastroenterology and Hepatology Board Review Toolkit, Second Edition. In an average day, the human gut produces up to 8 L of gas, and a balance needs to be constantly maintained in order to prevent its accumulation. There are only two forms of venting in humans: the passage of flatus and belching. Only the proximal and distal portions of the gut have the close proximity to the environment needed for venting to occur. In the central portions of the gut, the clearance of gas relies on three main mechanisms.

In the past erectile dysfunction pump.com generic sildenafila 100 mg with amex, liver allocation in the United States was based on both waiting time Practical Gastroenterology and Hepatology Board Review Toolkit erectile dysfunction ugly wife order sildenafila with visa, Second Edition impotence used in a sentence best sildenafila 100 mg. The 2-year survival of patients with decompensated cirrhosis is approximately 50% erectile dysfunction 7 seconds order generic sildenafila line, as compared to 80% in their compensated counterparts erectile dysfunction caused by jelqing purchase sildenafila 75 mg without prescription. Most transplant centers have specific protocols that are utilized to evaluate patients in a systematic fashion. The psychosocial evaluation is crucial to identifying patients who have adequate social support, strong probability of medical compliance, and low risk of chemical dependency relapse. In general, patients >65 years usually are good candidates for liver transplantation in the absence of any other serious comorbidity. The Mayo Clinic is currently performing a sleeve gastrectomy weight-loss surgery at the time of liver transplantation for highly selected candidates. Other centers are performing Roux-en-Y bariatric gastric bypass after recovery from liver transplantation. Other relative contraindications include severe muscle wasting/deconditioning, extensive previous abdominal surgeries or radiation treatment, extensive portomesenteric thromboses, and lack of social support. It is challenging to determine which patients may regain renal function after liver transplantation and which will remain in stage V chronic kidney disease requiring dialysis. Deceased versus Living Donor Liver Transplantation In the year 2012, 6256 adult liver transplants were performed: 6010 were deceased donor transplants and 246 were living donor transplants. Meanwhile, 2187 patients died while awaiting transplantation and 815 were removed from the waitlist because they were too sick. About 12,427 patients remained active on the liver transplantation waitlist at the end of 2012 [2]. Options to help narrow the gap between the supply of deceased donor livers and demand by waitlisted patients include the use of extended-criteria deceased donor livers and living donor liver transplantation. Living donor liver transplantation reached its peak in 2001 with 519 live donations. Living donor liver transplantation and deceased donor liver transplantation have similar rates of graft and patient survival. The benefits of living donor liver transplantation are the availability of a presumed high-quality graft, control over timing of the operation, decreased cold ischemia, and expansion of the donor pool. Alcoholic Liver Disease Alcoholic cirrhosis is the second most common indication for liver transplantation in the United States, accounting for approximately 24% of all liver transplants. The majority of patients have concomitant conditions, including hypertension, dyslipidemia, and diabetes, which are shared risk factors for coronary artery disease. Post transplantation, calcineurin inhibitors contribute to worsening hypertension, hyperlipidemia, and diabetes. Patients need close medical follow-up for optimal management of these problems, especially given the risks of drug­drug interactions. Many patients will also gain weight as they begin to feel well following liver transplantation, further compounding these metabolic conditions. Hepatitis C Hepatitis C continues to be the most common indication for liver transplantation (30%). However, it is currently undergoing a major paradigm shift with respect to liver transplantation, with the emergence of many new direct-acting viral agents that have displaced the need for pegylated inteferon. It is anticipated that screening strategies for all individuals born between 1945 and 1965 and more effective and better tolerated therapies will reduce the need for liver transplantation for this indication in future years. An arsenal of new direct acting antivirals have been approved in North America and Europe including Elbasvir/Grazoprevir, Ritonavir boosted Paritaprevir with Dasabuvir and Ombitasvir, Sofosbuvir, Sofosbuivr/Ledipasvir, Sofosbuvir/Daclatasvir, and Sofosbuvir/Simeprevir. In the era of pegylated interferon and ribavirin, decompensated cirrhotics and even compensated cirrhotics had difficulty tolerating this regimen and achieved low sustained virologic response (cure) rates. Most programs require 6 months of sobriety before listing for liver transplantation. A substantial proportion of patients may have improvement in liver function and portal hypertension with sustained abstinence, such that liver transplantation is no longer necessary. A French multicenter study prospectively examined the outcomes of early liver transplantation for severe alcoholic hepatitis (n = 26) and found a dramatic improvement in 6-month survival as compared to standard medical care (77 ± 8% vs. However, liver transplantation for alcoholic hepatitis is a controversial issue, and this practice has not been adopted for widespread use in the United States. In general, patients with alcoholic cirrhosis have excellent post-transplant survival, with >90% 1-year survival. The proportion of individuals who will go on to develop cirrhosis and decompensated cirrhosis is not entirely known. This decision requires careful thought and collaboration with the patient with reflection on their values. With respect to post-liver transplantation immunosuppression, there continues to be some debate about whether or not tacrolimus is better than cyclosporine for patients with hepatitis C. Recurrence of hepatitis C is more severe in patients with acute cellular rejection treated with bolus corticosteroids or thymoglobulin. Since tacrolimus is more effective at preventing acute cellular rejection, many opt to use it in this population. This is a relatively infrequent indication for liver transplantation, representing about 4­6% of cases in the United States and Europe. Those who present with acute hepatitis require immediate treatment with corticosteroids. Liver transplant outcomes are generally excellent for this population, though a recent report from Europe suggested a higher risk of death after the first year post transplantation. This is the fifth most common indication for liver transplantation in the United States. Classic features include a high bilirubin (>20 mg/dL) with elevated indirect fraction, low alkaline phosphatase and uric acid, and Coombs-negative hemolytic anemia in a young person. These patients receive top priority (status 1) for liver transplantation, and rarely survive without it. Iron-depletion therapy will not reverse the consequences of end-stage liver disease, so it is ideal to make the diagnosis of hereditary hemochromatosis and begin phlebotomy early. Patients with adequate iron depletion prior to liver transplantation probably have similar post-liver transplantation survival when compared to other indications for liver transplantation. In type 1 hyperoxaluria, there is a deficiency of hepatic alanine glyoxylate aminotransferase, with increased conversion of glyoxylate to oxalate and resultant renal failure. Familial amyloidotic polyneuropathy is another metabolic condition in which abnormal amyloid is produced by an otherwise normally functioning liver. The Milan criteria are one tumor 5 cm or two or three tumors no larger than 3cm [23]. For lesions that do not possess these radiologic features, but are growing, a high degree of suspicion must be maintained, and a targeted biopsy is usually required. The locoregional therapy of choice depends on tumor size, number, location, proximity to vasculature, and portal vein patency, as well as local expertise. For patients undergoing living donor liver transplant, a waiting period of 6 months after locoregional therapy has been advised to allow for observation of tumor behavior. The mass must be <3 cm in radial diameter, without intrahepatic or extrahepatic metastases, to be eligible for liver transplantation. Pretransplant protocols include external beam radiation, brachytherapy applied via a nasobiliary tube, chemotherapy, and laparoscopic operative staging [25]. Of the patients enrolled in a pre-liver transplantation protocol at the Mayo Clinic, approximately two-thirds went on to complete chemoradiation and received a liver transplant. The more severe the hypoxemia prior to liver transplantation, the longer it generally takes for patients to be weaned from supplemental oxygen after transplant, but liberation from supplemental oxygen is expected [26]. Portopulmonary syndrome should be suspected in patients with a high right ventricular systolic pressure >50 mmHg on transthoracic echocardiogram in the presence of portal hypertension. Resolution of portopulmonary hypertension post liver transplantation is less reliable, and about 50% of patients continue to need vasoactive therapy after transplant [26]. He will be a transplant candidate if the remainder of his pre-liver transplantation evaluation is satisfactory. Early referral of patients to a transplant center is preferable, to allow adequate time for evaluation and stabilization and so maximize the likelihood of a good outcome. If in doubt, always call the local transplant center before deeming a patient a poor candidate. Take Home Points r Successful liver transplantation requires optimal patient selection and transplantation timing. A revised Model for End-Stage Liver Disease optimizes prediction of mortality among patients awaiting liver transplantation. Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011. Program and Abstracts of the 64th Annual Meeting of the American Association for the Study of Liver Diseases. Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes. Waitlist survival of patients with primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Pulmonary contraindications, indications and meld exceptions for liver transplantation: a contemporary view and look forward. Fundamentals of organ allocation, hepatic anatomy, surgical technique, and risks of complications must be understood by all clinicians caring for liver transplant patients. Each phase of the transplant operation has unique physiologic circumstances, each with its own potential for success or failure. Biliary complications are most common, followed by hepatic arterial, portal venous, and hepatic venous complications. Introduction Orthotopic liver transplantation remains the only definitive treatment for end-stage liver disease. Though techniques have been refined and patient and graft survival have improved since 1963, liver transplantation remains a formidable surgical challenge. The technical complexities of the procedure can result in a variety of postoperative complications. Transplant hepatologists should be familiar with organ allocation, hepatic anatomy, and technical aspects of liver transplantation and its potential complications, in order to provide excellent care for these patients. The highest level of priority (status 1a) is given to patients with fulminant liver failure with an expected survival without transplant of less than 7 days. Additional priority is also given to children, to neutralize the difficulty of identifying size-matched organs. It is expected that this new policy change will allow timely transplant and decrease waitlist mortality for some gravely ill patients. First, it is thought there will be a significant Practical Gastroenterology and Hepatology Board Review Toolkit, Second Edition. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Eastern Vermont. Region 2: Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania, West Virginia, Northern Virginia. Region 3: Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, Puerto Rico. Surgical Anatomy of the Liver Donor Selection As with all organ transplantation, the availability and selection of donor organs are the foundations of successful liver transplantation. Considerations known to affect the quality of the organ include: cause of death (brain or cardiac death), donor age, whole or partial graft, donor race/ethnicity, size, steatosis, cold ischemia time, hypernatremia, and hemodynamic instability [2]. That year, however, criteria for determining brain death were described by an ad hoc committee at Harvard Medical School and reported in the Journal of the American Medical Association [3]. This report defined brain death, providing the foundation for the recognition of brain death in all 50 states. Organ donation after brain death allowed procurement of organs with minimal warm ischemic time and ushered in a new era in organ transplantation, which lasted a generation. The Pittsburgh group released a set of guidelines for recovering organs after the palliative withdrawal of life-prolonging measures leading to cardiac death [4, 5]. This led to a resurgence in the A thorough knowledge of hepatic anatomy, in particular the blood vessels and their relationship to the liver parenchyma, is important to understanding the nuances of liver transplantation. The liver lies in the right upper quadrant of the abdomen, suspended from the diaphragm by the triangular and coronary ligaments. The liver can be divided into eight segments, based upon the portal venous vascular supply and hepatic venous drainage. Each of these segments has its own arterial and portal blood supply and venous and biliary drainage, rendering each capable of functioning independently of the others. It is often disproportionally large in patients with cirrhosis, especially in conditions like Budd­Chiari syndrome, as the outflow from the caudate lobe is separate from the right, middle, and left hepatic venous drainage utilized by the rest of the liver. The liver is the only organ in the body that has dual inflow, through the portal vein and hepatic artery. Unlike the hepatic artery, the portal vein has few anatomic anomalies, the most common being trifurcation rather than classical bifurcation. Adult patients with cirrhosis are prone to developing thrombus in the portal vein due to stagnant venous flow. At the time of transplantation, portal venous thrombus can be carefully extracted from the portal vein in most cases. The surgical techniques used to deal with this condition are quite harrowing and may lead to a greater risk of post-transplant complications and intraoperative blood loss. Hiatt and colleagues described five classes of hepatic arterial anatomy in 1000 cases [10]. In three-quarters of all cases, the common hepatic artery arises as a branch of the celiac artery. The proper hepatic artery divides to form the right and left hepatic arteries in the porta hepatis. In less than 1% of people, a triple artery configuration exists, namely a simultaneous replaced or accessory right, left, and main hepatic arterial system. These anomalies are more important to recognize in the donor than in the recipient, as failure to notice and properly reconstruct the arterial inflow during a liver transplant can result in significant ischemia, especially to the biliary tree.

25 mg sildenafila visa. Erectile Dysfunction (ED) - Causes symptoms and treatment modalities.

For alcoholic hepatitis impotence trials france purchase sildenafila 100 mg on line, a number of pharmacologic treatment options have been evaluated erectile dysfunction treatment pdf sildenafila 25 mg discount, but current therapy still focuses on supportive care erectile dysfunction over 60 generic 75 mg sildenafila with visa. Lifestyle Modification the ultimate goal is to prevent disease progression and the possible development of decompensated cirrhosis and hepatocellular carcinoma erectile dysfunction treatment old age cheap 50 mg sildenafila with mastercard. People with alcohol problems are often heavy smokers as well discount erectile dysfunction drugs buy sildenafila with paypal, which may be a risk factor for progression of liver disease. Patients with end-stage liver disease have some degree of malnutrition, due to low nutrient intake and intestinal malabsorption. High protein Low fat Vitamin supplementation Corticosteroids Pentoxifylline disrupts the integrity of the immune system and impairs the ability to respond to infection. Enteral nutrition is favored because of its lower cost and because its positive effect on gut mucosal integrity confers a decreased risk of bacterial translocation and infections [3,15]. Patients should follow a high-protein diet supplemented with vitamins B, C, and K and folic acid. Obesity is also a risk factor for the development of steatosis, alcoholic hepatitis, and cirrhosis. The approach to lifestyle modification begins with reduction of alcohol intake, smoking cessation, weight control, and nutritional supplementation. Other Treatment Options Alcohol generates significant oxidative stress, as evidenced by the detection of lipid peroxidation products in the blood of alcoholics and in livers with alcoholic changes [8]. Therefore, antioxidants have been investigated as a potential therapeutic in alcoholic hepatitis. However, if infected patients are appropriately treated with antibiotics, their survival approaches that of non-infected patients. Typical recommended steroid courses consist of oral prednisolone 40 mg daily or parenteral methylprednisolone 32 mg daily for 4 weeks with a 4week taper [3]. When administering glucocorticosteroids to patients with hepatic encephalopathy, a course of prednisone 40 mg daily for 30 days is recommended [9]. Many transplantation units demand a 6-month alcohol abstinence period before considering transplantation. Though data are limited, a few studies suggest that a 6-month pre-transplant sobriety period decreases the likelihood of recidivism post-transplant. This period also allows for potential liver recovery without continued injury from alcohol. A reduction in the incidence of hepatorenal syndrome has also been reported in several studies [18]. Due to controversy surrounding the 6-month abstinence period, a recent trial evaluated early liver transplantation for alcoholic hepatitis patients who failed medical therapy with glucocorticoids. This study applied stringent selection criteria, including extensive social support and no history of prior decompensating events. It confirmed a 6-month survival benefit among patients undergoing early liver transplantation after failing medical management. While long-term follow up is required, no relapse of alcoholism was observed in the 6 months post-transplant [17]. Postgraduate course presented at the American Association of the Study of Liver Diseases. Systematic review: glucocorticosteroids for alcoholic hepatitis ­ a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. A randomized, double-blinded, placebocontrolled multicenter trial of etanercept in the treatment of alcoholic hepatitis. This is not surprising, given that liver plays a central role in the metabolism of drugs. Direct toxic liver damage is associated with acetaminophen toxicity, whereas most other drugs causing liver damage have an unpredictable or idiosyncratic pattern of injury. Clinical examination reveals tenderness over the liver and gallbladder, and abdominal ultrasound shows sludge in the gallbladder, which has wall thickening but no dilatation of the biliary tree. She is put on the waiting list for a liver transplantation due to a suspicion of isoniazid-induced liver failure, but dies on the waiting list 1 week later as no graft becomes available. Most liver injuries due to acetaminophen are associated with overdoses of the drug, and unintentional overdose without suicidal intent is increasingly observed with acetaminophen, especially in the United States [1]. In a retrospective study from the United Kingdom published more than 10 years ago, the highest crude incidence rates were found for chlorpromazine (1 in approximately 700 users), azathioprine and sulfasalazine (1 in 1000­1100 users), and amoxicillin-clavulanate (1 in approximately 11 000 users) [4]. A very similar incidence was extrapolated from a Swedish study at a university hospital over a 10-year period [6]. A 2-year population-based study from the whole country of Iceland demonstrated an incidence of 19 cases per 100 000 per year [5]. These results are somewhat higher than the incidence in the only other population-based study undertaken to date [7]. As mentioned earlier, the clinical and biochemical abnormalities are usually non-specific, and there are no markers or tests to confirm the causality. Some drugs have a "signature," showing a biochemical and histological pattern typical of the drug and immunoallergic manifestation, which makes the causality assessment easier. However, given the heterogeneity of presentations, the diagnosis relies on circumstantial evidence and "guilt by association" [13]. However, there are a number of pitfalls that the physician must bear in mind in the causality assessment. An important question in this context is whether the drug treatment was started before the patient developed symptoms indicative of liver disease, such as severe lethargy, nausea, and/or dark urin or pale stools. It is conceivable that the patient used the drug against symptoms associated with "hepatitis" or liver dysfunction of other etiology, for example. Thus, before a drug is "accused" of being responsible for liver test abnormalities, a reasonable exclusion of other causes of liver disease should be made (see later). When available, information about the last liver tests before the implicated drug was started can be of great value. Information about the duration of drug therapy is crucial to evaluating the time to onset of the drug reaction. For most idiosyncratic reactions, the latency period is approximately 1 week to a few months. Typically, immunoallergic reactions (fever, rash, eosinophilia) occur within a few weeks of exposure. Patients who have been taking some drugs with well-documented hepatotoxicity, such as nitrofurantoin, diclofenac, troglitazone, and ximelagatran, with normal liver tests for months, can unexpectedly develop hepatotoxicity, which can be severe. In the best-case scenario, an important part of the causality assessment is observing a rapid biochemical and clinical improvement after discontinuation of the implicated drug, called "positive dechallenge. It has been increasingly recognized that for some drugs with a clear potential of hepatotoxicity, liver tests can improve in some patients despite continuation of therapy. Before patients develop jaundice, symptoms of liver dysfunction are usually non-specific, but lethargy and nausea are common, and sometimes severe biochemical liver test abnormalities are detected in asymptomatic individuals. Most idiosyncratic drug reactions occur within 1 year of starting the drug, though there are some exceptions. A hepatitic pattern is typically observed in patients with isoniazid-, disulfiram-, and diclofenacassociated hepatotoxicity, whereas cholestatic injury is seen most often with amoxicillin/clavulanate, macrolide antibiotics, and estrogens [3]. The initial evaluation should include a thorough history of drug exposure, duration of therapy, previously recognized hepatotoxicity of the implicated drug, and the severity of the reaction. Patients with jaundice (without coagulopathy) due to idiosyncratic drug reactions need to be hospitalized, as they have risk of liver failure [10,12], and those with concomitant coagulopathy should be considered for liver transplantation. Acetaminophen As with idiosyncratic drug reactions, symptoms of liver injury due to acetaminophen are non-specific. Hepatic injury typically develops 12­72 hours after suicidal intent, and liver failure 72­96 hours after ingestion. However, it is obvious that susceptible individuals are unable to achieve such an "adaptation" to the liver injury and may go on to develop fatal hepatotoxicity [14]. Compared with hepatocellular or hepatitic reactions, improvement in liver tests is generally slower after discontinuation of drugs leading to cholestatic reactions [15]. So too is information about previously documented drug hepatotoxicity, which may add evidence in favor of a drug etiology in the reaction. Factors that may impact it include the type of liver injury, patient age, and symptomatology. In most cases, a reasonable examination is an abdominal ultrasound, though the information provided in typical hepatocellular (hepatitic) injury is limited. History of alcohol abuse should be documented, as should recent episodes of hypotension, which can cause hepatocellular liver injury. It is a common misconception that liver histology is essential for establishing a diagnosis of a toxic etiology. Thus, a routine liver biopsy is not indicated, and if one is undertaken late in the course of the reaction, it may induce confusion among clinicians. Acetaminophen Many of the principles of the diagnostic workup and the causality assessment are similar in cases of acetaminophen-induced liver injury. However, blood concentration of acetaminophen can be obtained early in the course of the reaction and is an important part of the management of a patient with a suspected and confirmed acetaminophen toxicity. However, this assay is not yet commercially available and its validity in clinical practice needs further study. The most common antibiotics implicated have been amoxicillin/clavulanic, erythromycin, flucloxacillin, trimethoprim-sulfa, and nitrofurantoin, but antituberculous drugs such as isoniazid and rifampicin have also commonly been observed in these series [5­7, 12, 17]. Obviously, if the patient has already experienced a liver injury from a particular drug, there is a great risk that this will happen again. Increasing age has been shown to be a risk factor for halothane, isoniazid, nitrofurantoin, and flucloxacillin [3]. Women have been found to be more susceptible to liver injury associated with halothane, flucloxacillin, isoniazid, nitrofurantoin, chlorpromazine, and erythromycin [3, 4, 15], whereas males have been found to have an increased risk of azathioprine-induced liver injury [3]. The late Hyman Zimmerman, the legendary researcher of drug hepatotoxicity, observed that autoimmune hepatitis was seen almost exclusively in women [15], and this has recently been confirmed [8, 20]. Similarly, treatment with statins in patients with hepatitis C and elevated liver tests seemed to be safe [21]. The prognosis is dependent on the severity of liver impairment that can develop in patients with hepatotoxicity. Zimmerman observed that the combination of hepatocellular injury (high aminotransferases) and jaundice was associated with a poor prognosis, with a fatality rate of 10­50% for the different drugs involved [15]. Studies from Spain and Sweden have recently confirmed these early observations and shown approximately 9­ 12% mortality/liver transplantation in patients with hepatocellular jaundice [10, 12]. Not only was hepatocellular liver injury due to drugs with jaundice found be a serious entity, but cholestatictype injury was associated with 6­8% mortality/transplantation rate [10, 12]. However, in general, the prognosis in patients with hepatocellular liver injury due to drugs is worse than in those with cholestatic/mixed pattern [10, 12]. The median duration between first exposure to the suspected drug was significantly longer in severe than in mild/moderate cases, in univariate but not in multivariate analysis [17]. The prognosis for drug-induced jaundice seems also to be dependent on the compound involved. In one study, mortality ranged from 40% with halothane-induced jaundice to 0% with erythromycin-induced jaundice, but the latter group was younger and had less severe liver injury [12]. Recently, the presence of both peripheral and hepatic eosinophilia in idiosyncratic liver injury has been reported to be associated with a better prognosis [11]. However, chronic liver disease, including liver cirrhosis, has been reported with a suspected causative link to a number of different drugs [28]. A prospective follow-up with the Spanish hepatotoxicity registry revealed a chronic evolution in 5. Patients with a cholestatic/mixed pattern of liver injury were more prone to development of chronic liver injury [30]. In general, the presence of encephalopathy and renal impairment is predictive of an unfavorable prognosis [1]. In a recent prospective study of patients hospitalized for acetaminopheninduced liver failure in the United States, 178 patients (65%) survived, 74 (27%) died without transplantation, and 23 (8%) underwent liver transplantation [31]. Transplant-free survival rate and rate of liver transplantation were similar between those with intentional (suicide attempt) and unintentional overdose [31]. It is obviously of crucial importance to assess the severity of the liver disease, and symptomatic patients with jaundice, encephalopathy, and/or coagulopathy should be hospitalized. Early contact should be made with a transplant center if the patient does not have an obvious contraindication for liver transplantation. Carnitine is recommended in valproate-associated hepatotoxicity [32], and though steroids are commonly used in patients with acute liver injury caused by idiosyncratic drug reactions, their Drug-Induced Liver Injury 507 use is not supported by any controlled studies. Some patients in the latter category may be excluded from transplantation due to age and comorbidities, but a larger proportion of acetaminophen cases have contraindication for transplantation, due to history of substance abuse, repeated suicidal behavior, and other psychosocial issues [1]. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Acute and clinically relevant druginduced liver injury: a population based case-control study. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Today erectile dysfunction doctor austin sildenafila 100 mg purchase line, shunts and bands are placed through a sternotomy approach and a patent ductus is ligated through ports using a video-assisted approach erectile dysfunction treatment dallas buy on line sildenafila. The thoracotomy for coarctation repair should be in the third or fourth space erectile dysfunction utah sildenafila 75 mg buy mastercard, but never the fifth icd 9 code erectile dysfunction neurogenic purchase line sildenafila. It is mainly a posterior rather than a lateral incision so that it should not be necessary to divide any of the serratus anterior psychological erectile dysfunction drugs buy sildenafila on line. Only a small amount of the trapezius should be divided and none of the erector spinae. The thoracotomy incision should be closed with absorbable pericostal sutures to avoid intercostal muscle compression by a permanent suture. The muscle layer is closed with a running absorbable suture, such as Vicryl, followed by a subcutaneous and subcuticular layer. In small, sick neonates, it is occasionally advisable to close the thick skin of the back with interrupted nylon sutures because this area is prone to breaking down, presumably because of its less-good blood supply and the fact that the child is lying on the incision. By carefully planning the sequence of the operation, the surgeon can optimize the exposure and the efficiency of the procedure. After the pulmonary arteries have been harvested from the truncus by transecting the trunk, one could then choose to reanastomose the aorta. A better approach is to perform the distal anastomosis of the homograft while the aorta is divided. The exposure of the homograft to pulmonary artery bifurcation is immeasurably better when the surgeon does not have to work over and behind the aorta. The advantage for the surgeon is that healing is rapid and risk of infection is low. However, the disadvantage is that Surgical Technique and Hemostasis 233 thawed and rinsed by the time it is needed, so this should have been done at an earlier phase of the procedure. Another example of sequencing which can shorten ischemic time is the repair of coarctation with hypoplastic arch. If a reverse subclavian flap is to be constructed to deal with the arch, then this should be done before ligating the duct. The distal aortic clamp is applied across the isthmus and the reverse subclavian flap is performed first, while the distal aorta is perfused by the patent duct. Subsequently, the clamps are moved to allow the duct to be ligated and divided and the coarctation to be resected and repaired by direct anastomosis. Walking oneself through the steps of an operation before the procedure itself should be an essential part of any procedure by any surgeon, no matter how experienced. The planning phase will also allow a decision to be made about the critically important issue of cannulation for cardiopulmonary bypass. Central cannulation is preferred for the vast majority of congenital cardiac procedures. The use of femoral or iliac cannulation has been discussed above in the setting of the reoperative sternotomy. The tip of the cannula will then project into the arch and will not "back-wall" which can result in swings in arterial line pressure. In fact, the small size of the ascending aorta in neonates and infants means that it is often useful to place the cannula in such a way that it will project into the arch rather than back-walling in the ascending aorta. Furthermore, a small rubber ring cut from a tourniquet should be placed on the cannula and adjusted to set the tip at an appropriate depth according to the size of the aorta. The small size of the aorta also means that the construction of the aortic pursestring suture is very important. The longer axis should never lie transversely as this will increase the risk that when the pursestring is tied down it may stenose the aorta. The different models and brands of arterial cannula that are available are discussed in Chapter 8, the Bypass Circuit: Hardware Options. Some specific, unusual arterial cannulation situations, such as for interrupted aortic arch and hypoplastic left heart syndrome, are discussed in the respective chapters. Venous cannuLaTion Single Venous Right Atrial Cannula A single venous cannula is placed within the right atrium for cooling to deep hypothermia for circulatory arrest and is also often used when the procedure will be limited to the left heart and there are no septal defects. It can be used for continuous bypass for neonates and small infants who do have septal defects when the majority of the procedure is extracardiac, such as the arterial switch procedure. The surgeon should always think about how the arterial cannula can be sited to optimize exposure. For example, for an arterial switch procedure it is important to place the cannula as distally as possible though there is no advantage in cannulating the arch as clamp placement might compromise innominate artery flow. If the pursestring lies transversely, there is a risk that a stenosis will be created. Advantages Apart from its simplicity one of the most important advantages of the single venous cannula is that it is highly unlikely that there will be unidentified venous obstruction during the bypass run. The surgeon is able to monitor the adequacy of venous drainage very easily by observing the degree of distention of the right atrium. Direct caval cannulation of the cavae causes an intimal injury that can be the site of thrombosis and, if the pursestring is excessively large, can result in stenosis of the cava. Disadvantages Entrainment of air into the venous line is one of the most important disadvantages of a single venous cannula. A large amount of air will break the siphon and require that the venous line be refilled. However, if the tricuspid valve is not congenitally abnormal and has not been distorted by surgery, it is usually possible to avoid or minimize this problem. A single venous cannula allows blood to enter the right heart and can allow more rapid rewarming of the myocardium than is seen with double venous cannulation. Since lower systemic temperatures are usually used in children than in adults, this is less of a problem than it is with adult surgery. Direct bicaval cannulation is generally preferred if the surgical approach is through the right atrium. It is important for the surgeon to understand that one or other cannula can be partially or even completely obstructed with little apparent change in hemodynamics. Obstruction can occur because too large a cannula has been selected and the side holes are occluded against the caval wall. The monitored perfusion pressure may actually rise and the venous saturation may also rise as the perfusate is redirected to the upper or lower half of the body, depending on which cannula has been occluded. These changes are likely to reassure rather than warn the surgical team that there is a problem. Even a central venous catheter may show no change as the tip is often below the caval tourniquet. The only warning sign may be that the perfusionist reports that volume is being lost from the circuit and that venous return is decreased. The surgeon should constantly look for changes in the relative venous saturations in the two cannulas. The blood returning from an obstructed cannula is usually much darker than normal. It is remarkable how minor an adjustment of the cannula is often required to correct the problem, emphasizing that the problem can also be caused by very little movement of the cannulas. The method of cannulation should be individualized depending on the relative sizes of the cavas and the presence or absence of a communicating innominate vein. Whatever technique is selected, near infrared spectroscopy is helpful in reassuring the surgical team that adequate venous drainage and oxygenation of the brain are being achieved. Venous Cannulation for the Bidirectional Glenn Shunt Experience with the Senning and Mustard procedures in neonates demonstrated that it was possible to rewarm the Surgical Technique and Hemostasis 235 patient after an atrial diversion procedure using the same venous cannulation site as was used for cooling, i. It is probably useful to occasionally inflate the lungs to reduce pulmonary resistance during this phase of the perfusion. While this technique works reasonably for the atrial switch procedures, it introduces an important risk if it is used for the bidirectional Glenn shunt (or hemi-Fontan procedure). In this situation, only blood returning from the upper body and most importantly the brain must pass through two resistance beds. This applies not only to the rewarming phase of the Glenn procedure itself, but also to the cooling phase of the subsequent Fontan procedure. The cannula should be small enough to allow flow to pass around it from the internal jugular vein opposite the side to which the cannula is directed. Left heart distention for only a few seconds causes injury to the myocardium and is probably one of the most important causes of postoperative low cardiac output. Left heart distention also causes pulmonary edema and is probably a frequent cause of so-called "postpump lung. There are many more potential causes of left heart distention in patients with congenital cardiac disease relative to adults with acquired cardiac disease. The most important cause is that left heart return is often increased because of cyanosis or the presence of major aortopulmonary collateral vessels. Aortopulmonary window, truncus arteriosus and anomalous coronary artery from the pulmonary artery are other anomalies where the surgeon must carefully guard against left heart distention. The right-angle cannula in the left innominate vein should be small enough to allow flow to pass around it from the internal jugular vein opposite the side to which the cannula is directed. Thus, the method for venting must be to drain the left ventricle itself while all the other causes can be dealt with by left atrial or pulmonary artery venting. As long as the left ventricle is able to eject the left heart return coming into it, there is not likely to be injury to the ventricle or the lungs. However, at the onset of bypass, the ionized calcium level drops acutely secondary to both hemodilution as well as the chelating effects of citrate in blood used in the pump prime, thereby reducing myocardial contractility. Hypothermia will slow the heart and reduce its ability to eject the left heart return. The surgeon needs to carefully monitor how well the ventricle is coping and should make a judgment as to when to place a left heart vent. Although some surgeons place a vent while the heart is beating and the aorta is not cross-clamped, this is not recommended, 236 Comprehensive Surgical Management of Congenital Heart Disease, Second Edition particularly if the heart is beating vigorously. There is a real risk that air will be entrained into the left heart through the incision in the left atrium or through the vent cannula as it is introduced. It is safer to wait until either the heart has fibrillated or the cross-clamp has been applied. The surgeon needs to watch the main pulmonary artery as the best guide to left heart distention because it is usually difficult to see the degree of left ventricular distention directly and it is usually not possible in young patients to insert a Swan­Ganz catheter. If the pulmonary artery is becoming tense and the heart has not fibrillated, the pump flow must be immediately reduced and the cross-clamp applied. While the cardioplegia is being infused, a vent can be inserted through the right superior pulmonary vein into the left atrium or across the mitral valve into the left ventricle. It is important to place the pursestring for the vent adjacent to the atrial septum, i. This will reduce the risk of bleeding if the same site is subsequently used for a left atrial monitoring line. However, care should be taken not to injure the sinus node or the sinus node artery. Alternative Methods of Venting It is important to appreciate that the pulmonary artery is directly connected to the left heart and is a potential site of left heart decompression. Although it is rare to insert a vent cannula into the pulmonary artery, it is common to have the pulmonary arteries open. Thus, a left atrial vent may not be necessary as long as the operation is sequenced such that the pulmonary arteries remain at least partially open until left heart contractility has been re-established. In repair of tetralogy, this can also be achieved by not completing the ventricular end of a transannular patch until the heart is beating reasonably vigorously because, in the absence of the pulmonary valve, the open right ventricle is a suitable site for venting. The presence of either a ventricular or an atrial septal defect increases the options for left heart venting. While there are many different methods for constructing vascular anastomoses that work well for individual surgeons, the following are some principles that have been found to be useful. The end-to-side anastomosis should incorporate principles of the patch plasty, as described below, because it involves critically important heel and toe sites. It allows a narrow segment of vessel to be incorporated in the anastomosis and avoids a circumferential anastomosis which reduces the risk that the anastomosis will be pursestringed. The anastomotic area is actually larger than the adjoining vessel and probably has better growth potential. It is often applied in the setting of a coarctation associated with arch or isthmus hypoplasia. Traditional surgical dogma would suggest that an interrupted suture technique should be used to permit growth and yet few congenital surgeons use anything other than running sutures. First, it has been found from clinical experience, for example, with the neonatal arterial switch procedure, that anastomoses do grow despite a running anastomosis. The suture is actually a spiral and like a spring it stretches out straight as the vessels enlarge. Whether it is fracture of fine 6/0 and 7/0 polypropylene sutures that permits growth, as has been claimed by many surgeons, is unproven. Clinical experience has also demonstrated that excessive tension on an anastomosis is a far more important cause of anastomotic stenosis than the suture technique. By placing multiple bites before the anastomosis is drawn together, the tension on each suture bite is reduced according to the principle of the block and tackle. The sailor raising a heavy sail is able to do so only because the tension on the rigging is reduced by a factor equal to the number of loops through the pulley. In the same way, as the surgeon pulls the multiple preliminary bites of an anastomosis together, there is less tendency for multiple small tears to occur at each bite because of the reduced tension on each bite. A continuous suture technique is very much faster than an interrupted technique and allows for a reduced ischemic time. Traditional dogma suggests that all vascular anastomoses should be constructed so as to evert the adventitia and allow intima-to-intima contact within the lumen of the anastomosis. It is the intima after all that produces prostacyclin and has other properties that minimize platelet adhesion and initiation of the coagulation cascade. An everting suture line can be achieved by suturing from the outside the vessel with either an over-and-over whip stitch or with a continuous horizontal mattress suture. However, this is not practical in many situations, for example, it is often necessary to suture the back wall of an anastomosis from within the lumen with the surgeon sewing forehand toward himself or herself.

References

• Pampiglione G, Privett G, Harden A. Tay-Sachs disease: neurophysiological studies in 20 children. Dev Med Child Neurol 1974;16:201.
• Logothetis DE, Kurachi Y, Galper J, et al: The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart, Nature 325:321-326, 1987.
• Sherwinter, D. A., Gupta, A., Eckstein, J. G. Natural orifice translumenal endoscopic surgery inguinal hernia repair: a survival canine model. J Laparoendosc Adv Surg Tech A. 2011; 21(3):209-212.
• Vissers R, McHugh D: Bispectral index monitoring as a continuous, noninvasive measure of sedation during procedures in the ED. Acad Emerg Med 7:529, 2000.
• Vanier MT, Wenger DA, Comley ME, et al. Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet 1988;33:331.
• Bellmunt J, von der Maase H, Mead GM, et al: Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987, J Clin Oncol 30:1107n1113, 2012.
• Slifkin M, Ruthazer R, Freeman R, et al. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transpl. 2005;11:1597-1602.
• Gesundheitsberichterstattung des Bundes. Heft 27: Schlafstorungen, Heft 28: Altersdemenz. Robert Koch Institut und Statistisches Bundesamt; Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: UCLA Brain Information Service, Brain Research Institute; Carskadon MA, Dement WC. Normal human sleep: an overview. In Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders Company; 2000: pp. 15-25.